[go: up one dir, main page]

MX2010008844A - Proceso para preparar derivados de piridona 226. - Google Patents

Proceso para preparar derivados de piridona 226.

Info

Publication number
MX2010008844A
MX2010008844A MX2010008844A MX2010008844A MX2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A MX 2010008844 A MX2010008844 A MX 2010008844A
Authority
MX
Mexico
Prior art keywords
route
preparing
pyridone derivatives
formula
preparing pyridone
Prior art date
Application number
MX2010008844A
Other languages
English (en)
Inventor
John Leonard
Mark Richard Fielding
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2010008844A publication Critical patent/MX2010008844A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Una ruta para la preparación de un compuesto de fórmula (I), en donde X, R1, R2, R7, R8 y R9 son tal como se describen y definen en la especificación. Proceso de las etapas seguidas en la ruta e intermediarios nuevos preparados durante la ruta también son descritos y reivindicados. Los compuestos de fórmula (I) son utilizados en la elaboración de compuestos farmacéuticos, en particular, los inhibidores de MEK, útiles en el tratamiento de enfermedades hiperproliferativas como el cáncer y las enfermedades inflamatorias.
MX2010008844A 2008-02-11 2009-02-09 Proceso para preparar derivados de piridona 226. MX2010008844A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2758208P 2008-02-11 2008-02-11
PCT/GB2009/050124 WO2009101432A2 (en) 2008-02-11 2009-02-09 Process for preparing pyridone derivatives 226

Publications (1)

Publication Number Publication Date
MX2010008844A true MX2010008844A (es) 2010-09-07

Family

ID=40677907

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010008844A MX2010008844A (es) 2008-02-11 2009-02-09 Proceso para preparar derivados de piridona 226.

Country Status (12)

Country Link
US (1) US20110015392A1 (es)
EP (1) EP2252588A2 (es)
JP (1) JP2011511784A (es)
KR (1) KR20100122921A (es)
CN (1) CN101939298A (es)
AU (1) AU2009213828A1 (es)
BR (1) BRPI0908782A2 (es)
CA (1) CA2713722A1 (es)
IL (1) IL207165A0 (es)
MX (1) MX2010008844A (es)
RU (1) RU2010137639A (es)
WO (1) WO2009101432A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101973936B (zh) * 2010-09-28 2012-02-08 太原理工大学 一种吡啶酮衍生物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
US20020019527A1 (en) * 2000-04-27 2002-02-14 Wei-Bo Wang Substituted phenyl farnesyltransferase inhibitors
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof

Also Published As

Publication number Publication date
AU2009213828A1 (en) 2009-08-20
RU2010137639A (ru) 2012-03-20
US20110015392A1 (en) 2011-01-20
WO2009101432A2 (en) 2009-08-20
KR20100122921A (ko) 2010-11-23
IL207165A0 (en) 2010-12-30
CA2713722A1 (en) 2009-08-20
WO2009101432A3 (en) 2009-10-22
BRPI0908782A2 (pt) 2017-06-13
CN101939298A (zh) 2011-01-05
EP2252588A2 (en) 2010-11-24
JP2011511784A (ja) 2011-04-14

Similar Documents

Publication Publication Date Title
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
MX2009010059A (es) Derivados de quinolina para el tratamiento de enfermedades inflamatorias.
PH12014500842A1 (en) Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
MY160785A (en) Manufacturing process for pyrimidine derivatives
IN2014MN02106A (es)
PH12013501704A1 (en) Substituted aminobutyric derivatives as neprilysin inhibitors
MX2012013274A (es) Novedosos derivados de la pirimidina.
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
TN2012000248A1 (en) Novel spiropiperidine compounds
PH12013500301A1 (en) Oxadiazole inhibitors of leukotriene production
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
TW200628154A (en) Organic compounds
EA201200471A1 (ru) Простые эфирные производные бициклических гетероарилов
UA99787C2 (en) Lactams as beta secretase inhibitors
SG179206A1 (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
EA201270302A1 (ru) Безводные формы производных пиридина
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
CY1113914T1 (el) Νεα παραγωγα διυδροϊνδολονων, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις οι οποιες τα περιεχουν
EA200801893A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве ингибиторов воспаления
MX355561B (es) Proceso para hacer inhibidores de girasa y topoisomerasa iv.
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
MX2010001512A (es) Nuevo procedimiento de preparacion.
MX2010008844A (es) Proceso para preparar derivados de piridona 226.
GEP20156350B (en) New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid

Legal Events

Date Code Title Description
FA Abandonment or withdrawal